Cogent Biosciences Inc — Cash Flow (NASDAQ:COGT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 35.85 M58.76 M118.64 M153.62 M207.79 M264.44 M 264.44 M Cash from investing activities 8.42 M1.72 M124.72 M97.82 M38.28 M399.53 M 399.53 M Cash from financing activities 232.2 M37.98 M163.56 M163.54 M214.45 M878.23 M 878.23 M Free cash flow 35.85 M57.04 M111.78 M150.83 M207.22 M262.89 M 262.89 M

News

Why Is Pfizer Stock Rising Tuesday? - Pfizer (NYSE:PFE)

Cogent Biosciences stock rises after FDA grants breakthrough therapy status

Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag - Cogent Biosciences (NASDAQ:COGT)

Thursday’s Insider Activity: GameStop CEO’s $21M Buy Stands Out

Cogent stock maintains Buy rating at H.C. Wainwright on NDA plans

Cogent Biosciences, Inc. (COGT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Raymond James reiterates Strong Buy on Cogent stock with $60 price target

UBS initiates Cogent stock with Buy rating, $60 price target

Cogent stock price target raised to $52 from $50 at H.C. Wainwright

Cogent Biosciences stock falls after multiple insider sales

Cogent stock maintains Strong Buy rating at Raymond James on NDA submission

Cogent Biosciences: Time For A Pause (NASDAQ:COGT)